Biofrontera Inc. (BFRI): Price and Financial Metrics

Biofrontera Inc. (BFRI): $2.09

0.09 (+4.50%)

POWR Rating

Component Grades

Momentum

C

Stability

F

Sentiment

Quality

D

Add BFRI to Watchlist
Sign Up

BFRI Price/Volume Stats

Current price $2.09 52-week high $13.42
Prev. close $2.00 52-week low $0.61
Day low $2.01 Volume 78,600
Day high $2.19 Avg. volume 711,690
50-day MA $1.23 Dividend yield N/A
200-day MA $5.13 Market Cap 10.64M

BFRI Stock Price Chart Interactive Chart >


Biofrontera Inc. (BFRI) Company Bio


Biofrontera Inc., a biopharmaceutical company, develops and provides dermatological products for the treatment of skin diseases in the United States. It primarily develops therapies for non-melanoma skin cancer. It offers Ameluz, an aminolevulinic acid hydrochloride gel for the photodynamic therapy of actinic keratoses; and BF-RhodoLED, an LED lamp emitting red light for use in photodynamic therapy. The company was founded in 1997 and is based in Woburn, Massachusetts.


BFRI Latest News Stream


Event/Time News Detail
Loading, please wait...

BFRI Latest Social Stream


Loading social stream, please wait...

View Full BFRI Social Stream

Latest BFRI News From Around the Web

Below are the latest news stories about BIOFRONTERA INC that investors may wish to consider to help them evaluate BFRI as an investment opportunity.

Biofrontera Inc. (BFRI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

After losing some value lately, a hammer chart pattern has been formed for Biofrontera Inc. (BFRI), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

Yahoo | November 22, 2023

Biofrontera Inc. (NASDAQ:BFRI) Q3 2023 Earnings Call Transcript

Biofrontera Inc. (NASDAQ:BFRI) Q3 2023 Earnings Call Transcript November 10, 2023 Operator: Good day, and welcome to the Biofrontera Inc. Third Quarter 2023 Financial Results and Business Update Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Tirth Patel with LHA Investor Relations. […]

Yahoo | November 11, 2023

Benign Growth For Biofrontera Inc. (NASDAQ:BFRI) Underpins Stock's 50% Plummet

To the annoyance of some shareholders, Biofrontera Inc. ( NASDAQ:BFRI ) shares are down a considerable 50% in the last...

Yahoo | November 11, 2023

Biofrontera Inc. Reports Third Quarter 2023 Financial Results and Provides a Business Update

Conference call begins at 10:00 a.m. Eastern time on Friday, November 10, 2023WOBURN, MA / ACCESSWIRE / November 9, 2023 / Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic ...

Yahoo | November 9, 2023

Biofrontera Inc. (BFRI) Upgraded to Buy: Here's What You Should Know

Biofrontera Inc. (BFRI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Yahoo | November 9, 2023

Read More 'BFRI' Stories Here

BFRI Price Returns

1-mo 34.84%
3-mo N/A
6-mo -56.73%
1-year -82.44%
3-year N/A
5-year N/A
YTD -24.55%
2023 -84.89%
2022 -87.81%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!